Immunological and Metabolomic Effects of Cry1Ab Protein and MON810 Maize in Mice
Author Information
Author(s): Karine Adel-Patient, Valeria D. Guimaraes, Alain Paris, Marie-Françoise Drumare, Sandrine Ah-Leung, Patricia Lamourette, Marie-Claire Nevers, Cécile Canlet, Jérôme Molina, Hervé Bernard, Christophe Créminon, Jean-Michel Wal
Primary Institution: INRA, UR496, Unité d'Immuno-Allergie Alimentaire, Jouy-en-Josas, France
Hypothesis
What are the immunological and metabolomic impacts of Cry1Ab protein and MON810 maize administration in mice?
Conclusion
The study found that Cry1Ab is immunogenic but does not exhibit allergenic potential, and no significant unintended effects of MON810 maize on immune responses were observed.
Supporting Evidence
- The study confirmed the immunogenicity of purified Cry1Ab without evidence of allergenic potential.
- Immune responses against maize proteins were quantitatively equivalent in mice treated with MON810 vs the non-GM counterpart.
- No specific anti-Cry1Ab antibody was detected in serum from mice given the GM maize extract.
- Metabolomic studies showed a slight 'cultivar' effect, representing less than 1% of the initial metabolic information.
Takeaway
Researchers gave mice a protein from genetically modified maize and looked at how their immune systems reacted. They found that the protein didn't cause allergies.
Methodology
Mice were administered purified Cry1Ab protein and MON810 maize extracts via different routes, and their immune responses and metabolic profiles were analyzed.
Potential Biases
Potential bias in the interpretation of immune responses due to the specific mouse model used.
Limitations
The study primarily focused on one mouse strain and may not represent responses in other strains or species.
Participant Demographics
Female BALB/cJ mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website